Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC

NCT02879097 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Carcinoma

Interventions

BIOLOGICAL: CBT124
BIOLOGICAL: EU-sourced Avastin®
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Cipla BioTec Pvt. Ltd.